BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aksu O, Aydın B, Doguç DK, Ilhan I, Ozturk O, Altuntas A, Demirkan H, Koroglu BK, Tamer MN. The evaluation of Nesfatin-1 levels in patients with OSAS associated with metabolic syndrome. J Endocrinol Invest 2015;38:463-9. [DOI: 10.1007/s40618-014-0216-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Tekin T, Cicek B, Konyaligil N. Regulatory Peptide Nesfatin-1 and its Relationship with Metabolic Syndrome. Eurasian J Med 2019;51:280-4. [PMID: 31692710 DOI: 10.5152/eurasianjmed.2019.18420] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
2 Ünal K, Yüksel RN, Turhan T, Sezer S, Yaylaci ET. The association of serum nesfatin-1 and ghrelin levels with metabolic syndrome in patients with schizophrenia. Psychiatry Research 2018;261:45-9. [DOI: 10.1016/j.psychres.2017.12.041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Luo JJ, Wen FJ, Qiu D, Wang SZ. Nesfatin-1 in lipid metabolism and lipid-related diseases. Clin Chim Acta 2021;522:23-30. [PMID: 34389280 DOI: 10.1016/j.cca.2021.08.005] [Reference Citation Analysis]
4 Ceccato F, Bernkopf E, Scaroni C. Sleep apnea syndrome in endocrine clinics. J Endocrinol Invest 2015;38:827-34. [DOI: 10.1007/s40618-015-0338-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
5 Ahmed KS, Esbhani UA, Naseem Z, Lalani S, Fatima SS. Molecular basis of non-alcoholic fatty liver disease and metabolic syndrome in a subset of South Asians. Int J Diabetes Dev Ctries 2021;41:435-40. [DOI: 10.1007/s13410-020-00906-4] [Reference Citation Analysis]
6 Algul S, Ozkan Y, Ozcelik O. Serum Nesfatin-1 Levels in Patients With Different Glucose Tolerance Levels. Physiol Res. [DOI: 10.33549/physiolres.933186] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
7 Dore R, Levata L, Lehnert H, Schulz C. Nesfatin-1: functions and physiology of a novel regulatory peptide. Journal of Endocrinology 2017;232:R45-65. [DOI: 10.1530/joe-16-0361] [Cited by in Crossref: 64] [Cited by in F6Publishing: 20] [Article Influence: 12.8] [Reference Citation Analysis]
8 Qu Y, Ye JY, Han DM, Zheng L, Cao X, Zhang YH, Ding X. Esophageal Functional Changes in Obstructive Sleep Apnea/Hypopnea Syndrome and Their Impact on Laryngopharyngeal Reflux Disease. Chin Med J (Engl) 2015;128:2162-7. [PMID: 26265608 DOI: 10.4103/0366-6999.162506] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
9 Wang R, Wang J, Wan X. Association of the Polymorphism in Nucleobindin 2 Gene and the Risk of Metabolic Syndrome. Genetic Testing and Molecular Biomarkers 2016;20:49-52. [DOI: 10.1089/gtmb.2015.0194] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
10 Mechanick JI, Zhao S, Garvey WT. The Adipokine-Cardiovascular-Lifestyle Network. Journal of the American College of Cardiology 2016;68:1785-803. [DOI: 10.1016/j.jacc.2016.06.072] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
11 Sahin FK, Sahin SB, Ural UM, Cure MC, Senturk S, Tekin YB, Balik G, Cure E, Yuce S, Kirbas A. Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome. Bosn J Basic Med Sci 2015;15:57-63. [PMID: 26295295 DOI: 10.17305/bjbms.2015.432] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
12 Tekin T, Çiçek B, Konyalıgil N, Güntürk İ, Yazıcı C, Karaca Z, Ünlüsavuran M. Increased hip circumference in individuals with metabolic syndrome affects serum nesfatin-1 levels. Postgrad Med J 2020;96:600-5. [DOI: 10.1136/postgradmedj-2019-136887] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sahin FK, Sahin SB, Ural UM, Cure MC, Senturk S, Tekin YB, Balik G, Cure E, Yuce S, Kirbas A. Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome. Bosn J Basic Med Sci 2015;15:57-63. [PMID: 26295295 DOI: 10.17305/bjbms.2015.432] [Reference Citation Analysis]
14 Ciftci K, Guvenc G, Kasikci E, Yalcin M. Centrally and peripherally injected nesfatin-1-evoked respiratory responses. Respir Physiol Neurobiol 2019;267:6-11. [PMID: 31152893 DOI: 10.1016/j.resp.2019.05.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]